106 related articles for article (PubMed ID: 32329786)
1. Novel synthetic lipopeptides derived from Mycoplasma hyorhinis upregulate calpastatin in SH-SY5Y neuroblastoma cells and induce a neuroprotective effect against amyloid-β-peptide toxicity.
Kornspan JD; Kosower NS; Vaisid T; Katzhandler J; Rottem S
FEMS Microbiol Lett; 2020 May; 367(10):. PubMed ID: 32329786
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effects of Mycoplasma hyorhinis against amyloid-β-peptide toxicity in SH-SY5Y human neuroblastoma cells are mediated by calpastatin upregulation in the mycoplasma-infected cells.
Elkind E; Vaisid T; Kornspan JD; Barnoy S; Rottem S; Kosower NS
Neurochem Int; 2011 Mar; 58(4):497-503. PubMed ID: 21219955
[TBL] [Abstract][Full Text] [Related]
3. Calpastatin is upregulated in non-immune neuronal cells via toll-like receptor 2 (TLR2) pathways by lipid-containing agonists.
Vaisid T; Kosower NS
Biochim Biophys Acta; 2013 Oct; 1833(10):2369-77. PubMed ID: 23773963
[TBL] [Abstract][Full Text] [Related]
4. Calpastatin upregulation in Mycoplasma hyorhinis-infected cells is promoted by the mycoplasma lipoproteins via the NF-κB pathway.
Elkind E; Vaisid T; Kornspan JD; Barnoy S; Rottem S; Kosower NS
Cell Microbiol; 2012 Jun; 14(6):840-51. PubMed ID: 22288381
[TBL] [Abstract][Full Text] [Related]
5. Mycoplasma hyorhinis upregulates calpastatin and inhibits calpain-dependent proteolysis in SH-SY5Y neuroblastoma cells.
Elkind E; Rechnitzer H; Vaisid T; Kornspan JD; Barnoy S; Rottem S; Kosower NS
FEMS Microbiol Lett; 2010 Mar; 304(1):62-8. PubMed ID: 20100284
[TBL] [Abstract][Full Text] [Related]
6. Calpastatin reduces calpain and caspase activation in methamphetamine-induced toxicity in human neuroblastoma SH-SY5Y cultured cells.
Suwanjang W; Phansuwan-Pujito P; Govitrapong P; Chetsawang B
Neurosci Lett; 2012 Sep; 526(1):49-53. PubMed ID: 22897874
[TBL] [Abstract][Full Text] [Related]
7. Calpastatin overexpression reduces oxidative stress-induced mitochondrial impairment and cell death in human neuroblastoma SH-SY5Y cells by decreasing calpain and calcineurin activation, induction of mitochondrial fission and destruction of mitochondrial fusion.
Tangmansakulchai K; Abubakar Z; Kitiyanant N; Suwanjang W; Leepiyasakulchai C; Govitrapong P; Chetsawang B
Mitochondrion; 2016 Sep; 30():151-61. PubMed ID: 27453331
[TBL] [Abstract][Full Text] [Related]
8. Trichostatin A epigenetically increases calpastatin expression and inhibits calpain activity and calcium-induced SH-SY5Y neuronal cell toxicity.
Seo J; Jo SA; Hwang S; Byun CJ; Lee HJ; Cho DH; Kim D; Koh YH; Jo I
FEBS J; 2013 Dec; 280(24):6691-701. PubMed ID: 24200051
[TBL] [Abstract][Full Text] [Related]
9. Methamphetamine toxicity-induced calcineurin activation, nuclear translocation of nuclear factor of activated T-cells and elevation of cyclooxygenase 2 levels are averted by calpastatin overexpression in neuroblastoma SH-SY5Y cells.
Chetsawang J; Nudmamud-Thanoi S; Phonchai R; Abubakar Z; Govitrapong P; Chetsawang B
Neurotoxicology; 2018 Jul; 67():287-295. PubMed ID: 29944913
[TBL] [Abstract][Full Text] [Related]
10. The protective effect of melatonin on methamphetamine-induced calpain-dependent death pathway in human neuroblastoma SH-SY5Y cultured cells.
Suwanjang W; Phansuwan-Pujito P; Govitrapong P; Chetsawang B
J Pineal Res; 2010 Mar; 48(2):94-101. PubMed ID: 20050990
[TBL] [Abstract][Full Text] [Related]
11. Calpains and calpastatin in SH-SY5Y neuroblastoma cells during retinoic acid-induced differentiation and neurite outgrowth: comparison with the human brain calpain system.
Grynspan F; Griffin WB; Mohan PS; Shea TB; Nixon RA
J Neurosci Res; 1997 May; 48(3):181-91. PubMed ID: 9160241
[TBL] [Abstract][Full Text] [Related]
12. Calpastatin overexpression attenuates amyloid-beta-peptide toxicity in differentiated PC12 cells.
Vaisid T; Barnoy S; Kosower NS
Neuroscience; 2008 Oct; 156(4):921-31. PubMed ID: 18786620
[TBL] [Abstract][Full Text] [Related]
13. Melatonin attenuates dexamethasone toxicity-induced oxidative stress, calpain and caspase activation in human neuroblastoma SH-SY5Y cells.
Suwanjang W; Abramov AY; Govitrapong P; Chetsawang B
J Steroid Biochem Mol Biol; 2013 Nov; 138():116-22. PubMed ID: 23688838
[TBL] [Abstract][Full Text] [Related]
14. The protective underlying mechanisms of Schisandrin on SH-SY5Y cell model of Alzheimer's disease.
Zhao ZY; Zhang YQ; Zhang YH; Wei XZ; Wang H; Zhang M; Yang ZJ; Zhang CH
J Toxicol Environ Health A; 2019; 82(19):1019-1026. PubMed ID: 31739764
[TBL] [Abstract][Full Text] [Related]
15. Beta-VLDL protects against A beta(1-42) and apoE toxicity in human SH-SY5Y neuroblastoma cells.
Cedazo-Mínguez A; Hüttinger M; Cowburn RF
Neuroreport; 2001 Feb; 12(2):201-6. PubMed ID: 11209921
[TBL] [Abstract][Full Text] [Related]
16. Borneol alleviates oxidative stress via upregulation of Nrf2 and Bcl-2 in SH-SY5Y cells.
Hur J; Pak SC; Koo BS; Jeon S
Pharm Biol; 2013 Jan; 51(1):30-5. PubMed ID: 23134284
[TBL] [Abstract][Full Text] [Related]
17. CRMP2-derived peptide ST2-104 (R9-CBD3) protects SH-SY5Y neuroblastoma cells against Aβ
Ji Y; Hu Y; Ren J; Khanna R; Yao Y; Chen Y; Li Q; Sun L
Chem Biol Interact; 2019 May; 305():28-39. PubMed ID: 30871964
[TBL] [Abstract][Full Text] [Related]
18. Liraglutide prevents beta-amyloid-induced neurotoxicity in SH-SY5Y cells via a PI3K-dependent signaling pathway.
Liu XY; Wang LX; Chen Z; Liu LB
Neurol Res; 2016 Apr; 38(4):313-9. PubMed ID: 27108910
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effect of neuropeptide Y against β-amyloid 25-35 toxicity in SH-SY5Y neuroblastoma cells is associated with increased neurotrophin production.
Croce N; Dinallo V; Ricci V; Federici G; Caltagirone C; Bernardini S; Angelucci F
Neurodegener Dis; 2011; 8(5):300-9. PubMed ID: 21346312
[TBL] [Abstract][Full Text] [Related]
20. In vitro evaluation of the protective effects of plant extracts against amyloid-beta peptide-induced toxicity in human neuroblastoma SH-SY5Y cells.
Sereia AL; de Oliveira MT; Baranoski A; Marques LLM; Ribeiro FM; Isolani RG; de Medeiros DC; Chierrito D; Lazarin-Bidóia D; Zielinski AAF; Novello CR; Nakamura CV; Mantovani MS; Mello JCP
PLoS One; 2019; 14(2):e0212089. PubMed ID: 30763379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
